Compared with the normal group, the positive expression of CD31 in the DOX-HF group decreased significantly (p < 0.05); on the contrary, the treatment of aFGF-NP + UTMD could significantly prevent the decrease of positive expression of CD31 compared with the DOX-HF group (p < 0.05). The gene discussed is FGF1; the disease is hydrops fetalis.